School of Medicine
Showing 541-560 of 869 Results
-
Hoang Minh Hieu Nguyen
MD Student with Scholarly Concentration in Molecular Basis of Medicine / Surgery, expected graduation Spring 2030
BioHoang Minh Hieu Nguyen, from Di Linh, Vietnam, is pursuing an MD at Stanford School of Medicine. They earned a bachelor’s degree in neuroscience from Middlebury College and a master of philosophy in clinical neurosciences from the University of Cambridge. Hieu aspires to combine science, the arts, and entrepreneurship to improve healthcare quality and access for global populations burdened by chronic disease. Hieu has contributed to advancing our understanding of cancer and neurodegenerative diseases through research at Middlebury College, Rockefeller University, Memorial Sloan Kettering Cancer Center, University of Cambridge, and Dana-Farber Cancer Institute. As a Social Entrepreneurship Fellow at Middlebury, they collaborated with the Kenyan Ministry of Health and the World Telehealth Initiative to establish Kenya’s first telemedicine system. This program provides lifesaving services, including dialysis, to Longisa, where such services were once unreachable.
-
Chloe Nobuhara
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2025
BioDr. Nobuhara is a general surgery resident at Stanford, currently pursuing a postdoctoral research fellowship in Surgical Artificial Intelligence (AI) at Deutsches Krebsforschungszentrum (DKFZ, German Cancer Research Center) in Heidelberg, Germany. She has currently completed three years of general surgery residency and is completing her two-year professional development track, before returning to residency in June 2027. Her research explores where AI can be successfully implemented into surgical practice. She has used computer vision and vision-language models for surgical performance assessment with Stanford’s Medical AI and Computer Vision Lab (MARVL), worked with Aimbient on OR artificial intelligence and automated documentation, and now helps lead ORena, a MICCAI challenge on identifying surgical foreign bodies from long-context video.
Originally from Honolulu, Hawaii, she holds an MD from Duke University and an undergraduate degree from Northeastern University. She is dedicated to upholding patient safety standards while pursuing aggresive surgical innovation. -
Peter Nonso Nwokoye
MD Student with Scholarly Concentration in Bioengineering, expected graduation Spring 2028
BioPeter Nonso Nwokoye was born and raised in Nigeria and graduated summa cum laude with dual Bachelor of Science degrees in Chemistry and Biology from Barry University. During his undergraduate studies, he worked on the synthesis of selective muscarinic receptor agonists and antagonists. In 2021, he was awarded the prestigious Gates Cambridge Scholarship to study at King's College, University of Cambridge. There, under the mentorship of Professor Anthony Davenport, he researched the expression and signaling of the apelin receptor and its endogenous agonists, Elabela and Apelin, in glioblastoma stem cells. This experience sparked his interest in developing novel methods to deorphanize orphan Class A GPCRs. After several months of intensive computational research, Peter developed a complex, multi-layered bioinformatic tool that he has used to identify likely endogenous ligands of orphan GPCRs, focusing on peptide ligands found in annotated uncharacterized open reading frames in the human genome. In his free time, he enjoys soccer, running, meditating, and teaching. Peter is excited about pursuing a career as a physician-scientist.
-
Marcus Oehlrich, PhD
Masters Student in Biomedical Data Science, admitted Autumn 2025
BioI am a Professor of Finance, Accounting, and Taxation, Head of the Management Department, and Vice President at accadis University of Applied Sciences in Bad Homburg, Germany. I am also a CFA charterholder and advise on start-ups, business valuation, and corporate finance. My consulting projects range from work with biotechnology start-ups and M&A transactions in the pharmaceutical and biotech sectors to preparing the business plan for the IPO of an international music and movie production group.
During my business studies, I became interested in law and medicine, particularly cancer research. I went on to complete a Master of Science in Pharmaceutical Medicine, a Certificate in Pharmaceutical Law, and an MPH at the Harvard T.H. Chan School of Public Health. I am currently pursuing an M.S. in Biomedical Data Science at Stanford University School of Medicine through the part-time Honors Cooperative Program (HCP).
I also had the privilege of serving as the CEO of the Institute for German, European, and International Medical Law, Health Law, and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) from 2005 to 2011. At accadis University of Applied Sciences, I am Head of the Health Care Management Research Group and responsible for the Master of Arts in International Health Care Management. From 2010 to 2020, I served as the Honorary Consul of the Republic of San Marino in Frankfurt, Germany.
Most of my publications (12 books and more than 70 articles) are related to business topics. However, I also authored three books on cancer "Internetkompass Krebs [Internet compass cancer]" (Springer 2001), "Recombinant humanized monoclonal antibody Trastuzumab for the treatment of metastatic breast cancer with tumors overexpressing the HER2/neu proto-oncogene: A systematic review" (dissertation.de 2003) and "Krebs vorbeugen und bekämpfen [Preventing and combating cancer: All about prevention, early detection, therapy]" (Reader's Digest 2012). The latter was translated into Polish, Czech, Croatian, Slovenian, and Hungarian.